Govt Announces Free HPV Vaccines For Adolescent Girls To Prevent Cervical Cancer: What It Is And Its Impact

In a major step to improve women's health and prevent cervical cancer, the central government is preparing to launch a nationwide Human Papillomavirus (HPV) vaccination programme for adolescent girls.

Health Ministry sources said the initiative will provide free vaccines through government health facilities and will mainly target girls around the age of 14.

The programme aims to reduce the number of cervical cancer cases in India through early prevention.

Free Vaccination Across Government Health Facilities

Under the upcoming programme, HPV vaccines will be available free of cost at several government healthcare centres, including:

• Ayushman Arogya Mandirs
• Community health centres and district hospitals
• Government medical colleges

The vaccination will be voluntary and conducted under the supervision of trained medical officers. Authorities said proper systems will be in place to monitor recipients after vaccination and manage any rare side effects.

With this initiative, India will join more than 160 countries that have already introduced HPV vaccination in their national immunisation programmes.

Vaccine Supply and Approval Process

Vaccine supplies for the nationwide rollout have been secured through India's partnership with Gavi, the Vaccine Alliance. Officials said this ensures high-quality vaccines that meet strict safety and storage standards.

The decision to launch the programme follows scientific review and recommendations from the National Technical Advisory Group on Immunisation (NTAGI).

India will use the quadrivalent HPV vaccine Gardasil, which protects against the most harmful HPV types linked to cervical cancer as well as those causing genital warts.

Why This Programme Is Important

Cervical cancer remains one of the most serious health concerns for women in India. It is currently the second most common cancer among Indian women.

According to official data:

Around 80,000 new cervical cancer cases are reported every year
More than 42,000 women die annually due to the disease
Over 80% of cases are linked to high-risk HPV types, mainly HPV 16 and 18
Health experts say early vaccination can significantly reduce these numbers in the coming decades.

Globally, more than 500 million doses of HPV vaccines have already been administered since 2006. Studies show the vaccine is highly effective - between 93% and 100% - in preventing cervical cancer caused by targeted HPV types.

What is HPV?

Human Papillomavirus (HPV) refers to a group of common viruses that spread mainly through close skin-to-skin contact.

Most HPV infections go away on their own without causing harm. However, some high-risk types can remain in the body for years and may lead to cervical cancer over time if not treated or prevented.

Types 16 and 18 of HPV are responsible for the majority of cervical cancer cases.

Why Girls Aged 14 Are Being Targeted

Health authorities recommend vaccination at a younger age because the vaccine works best before exposure to the virus.

Giving the vaccine at around 14 years ensures:

• Strong and long-lasting immunity
• Protection before possible infection
• Significant reduction in future cancer risk

Research reviewed by global and Indian health bodies shows that vaccination at this age provides durable protection.

Single-Dose Option and Global Guidelines

Recent global studies suggest that even a single dose of the HPV vaccine can offer strong protection. The World Health Organization and its advisory groups have reviewed evidence indicating that a single-dose schedule may provide protection comparable to two-dose regimens for most adolescents.

However, individuals with weakened immunity or certain health conditions may still require additional doses.

A single-dose schedule can also make vaccination programmes more affordable and easier to implement, improving coverage across large populations.

A Step Towards Better Preventive Healthcare

Health experts believe that introducing free HPV vaccination nationwide will be a major step toward strengthening preventive healthcare for women in India.
By protecting girls at an early age, the programme aims to significantly reduce cervical cancer cases and deaths in the future.

Once fully implemented, the initiative could play a crucial role in improving women's health outcomes and ensuring a healthier next generation.